| Tretinoin | Approved Investigational Nutraceutical | DOK2 | 9046 |
upregulated | Tretinoin results in increased expression of DOK2 mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DOK4 | 55715 |
downregulated | Tretinoin results in decreased expression of DOK4 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | DOK7 | 285489 |
downregulated | Tretinoin results in decreased expression of DOK7 mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DPF3 | 8110 |
upregulated | Tretinoin results in increased expression of DPF3 mRNA | 14q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DPH1 | 1801 |
upregulated | Tretinoin results in increased expression of DPH1 mRNA | 17p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DPH2 | 1802 |
downregulated | Tretinoin results in decreased expression of DPH2 mRNA | 1p34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DPH5 | 51611 |
downregulated | Tretinoin results in decreased expression of DPH5 mRNA | 1p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DPP6 | 1804 |
upregulated | Tretinoin results in increased expression of DPP6 mRNA | 7q36.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DPPA3 | 359787 |
downregulated | Tretinoin results in decreased expression of DPPA3 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | DPPA4 | 55211 |
downregulated | Tretinoin results in decreased expression of DPPA4 mRNA | 3q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | DPT | 1805 |
downregulated | Tretinoin results in decreased expression of DPT mRNA | 1q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DPY19L1P1 | 100129460 |
upregulated | Tretinoin results in increased expression of DPY19L1P1 mRNA | 7p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DPYSL2 | 1808 |
downregulated | Tretinoin results in decreased expression of DPYSL2 mRNA | 8p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DPYSL3 | 1809 |
downregulated | Tretinoin results in decreased expression of DPYSL3 mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | DPYSL3 | 1809 |
upregulated | Tretinoin results in increased expression of DPYSL3 mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | DRAM1 | 55332 |
upregulated | Tretinoin results in increased expression of DRAM1 mRNA | 12q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DRAP1 | 10589 |
upregulated | Tretinoin results in increased expression of DRAP1 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DRAXIN | 374946 |
downregulated | Tretinoin results in decreased expression of DRAXIN mRNA | 1p36.22 | |
| Tretinoin | Approved Investigational Nutraceutical | DRD2 | 1813 |
upregulated | Tretinoin results in increased expression of DRD2 mRNA | 11q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | DSC1 | 1823 |
downregulated | Tretinoin metabolite results in decreased expression of DSC1 mRNA | 18q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DSC1 | 1823 |
downregulated | Tretinoin results in decreased expression of DSC1 mRNA | 18q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DSC2 | 1824 |
upregulated | Tretinoin results in increased expression of DSC2 mRNA | 18q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DSP | 1832 |
upregulated | Tretinoin results in increased expression of DSP mRNA | 6p24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | DST | 667 |
downregulated | Tretinoin results in decreased expression of DST mRNA | 6p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | DTX1 | 1840 |
upregulated | Tretinoin results in increased expression of DTX1 mRNA | 12q24.13 | |